Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Palexia SR 100mg tablets
0407020AGBBADAD
|
Palexia | Tapentadol | Central Nervous System | 467 |
|
Risperidone 25mg inj vials
0402020AAAAAAAA
|
Risperidone (Parenteral) | Risperidone | Central Nervous System | 467 |
|
Risperidone 37.5mg inj vials
0402020AAAAACAC
|
Risperidone (Parenteral) | Risperidone | Central Nervous System | 466 |
|
Seroquel 300mg tablets
0402010ABBBAGAK
|
Seroquel | Quetiapine | Central Nervous System | 466 |
|
Solpadeine Max soluble tablets
0407010X0BMADA0
|
Solpadeine | Paracetamol combined preparations | Central Nervous System | 465 |
|
Melatonin 3mg/5ml oral solution
0401010ADAACACA
|
Melatonin | Melatonin | Central Nervous System | 463 |
|
Lyrica 225mg capsules
0408010AEBBAHAI
|
Lyrica | Pregabalin | Central Nervous System | 458 |
|
Abilify 15mg tablets
0402010ADBBABAB
|
Abilify | Aripiprazole | Central Nervous System | 456 |
|
Stanek 75mg/18.75mg/200mg tablets
0409010X0BDAAAE
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 455 |
|
Exelon 4.6mg/24hours transdermal patches
0411000E0BBAFAF
|
Exelon | Rivastigmine | Central Nervous System | 451 |
|
Paracetamol 1g suppositories
0407010H0AABNBN
|
Paracetamol | Paracetamol | Central Nervous System | 448 |
|
Levodopa 175mg / Carbidopa 43.75mg / Entacapone 200mg tab
0409010X0AAAGAG
|
Levodopa/carbidopa/entacapone | Levodopa/carbidopa/entacapone | Central Nervous System | 447 |
|
Xenical 120mg capsules
0405010P0BBAAAA
|
Xenical | Orlistat | Central Nervous System | 447 |
|
Sodium valproate 1g modified-release gran sachets sugar free
0408010W0AABTBT
|
Sodium valproate | Sodium valproate | Central Nervous System | 445 |
|
Stanek 175mg/43.75mg/200mg tablets
0409010X0BDACAG
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 445 |
|
Migard 2.5mg tablets
0407041ABBBAAAA
|
Migard | Frovatriptan | Central Nervous System | 443 |
|
Seroquel XL 150mg tablets
0402010ABBBALBA
|
Seroquel | Quetiapine | Central Nervous System | 443 |
|
Targinact 40mg/20mg modified-release tablets
0407020AFBBADAD
|
Targinact | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 443 |
|
Ationdo SR 150mg tablets
0407020AGBCADAE
|
Ationdo | Tapentadol | Central Nervous System | 442 |
|
Adartrel 250microgram tablets
0409010H0BCABAA
|
Adartrel | Ropinirole hydrochloride | Central Nervous System | 439 |
|
Oxylan 20mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFACAG
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 439 |
|
APO-go POD 100mg/20ml solution for infusion cartridges
0409010A0BCAEBB
|
APO-go | Apomorphine hydrochloride | Central Nervous System | 438 |
|
Briviact 50mg tablets
0408010ALBBACAC
|
Briviact | Brivaracetam | Central Nervous System | 438 |
|
Benperidol 250microgram tablets
0402010B0AAAAAA
|
Benperidol | Benperidol | Central Nervous System | 434 |
|
Paliperidone 50mg/0.5ml prolonged-release inj pf syringes
0402020ABAAAAAA
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 433 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.